Pharma/Biotech - Page 1 | TalkMarkets

Blogs

All Posts > Content under Pharma/Biotech
1 to 16 of 3660 Posts
1 2 3 ... 229
Bulls And Bears Of The Week: Chevron, Oracle, Twitter And More
Article By: Benzinga
Saturday, September 26, 2020 5:55 PM EDT
Here are a few of this past week's most bullish and bearish posts that are worth another look.
In this article: AXP, AZN, CVX, AAPL, ORCL, MRNA, TWTR, DKNG
Read
Biotech Tools Boost 10X Genetics
Article By: MoneyShow.com
Saturday, September 26, 2020 4:23 PM EDT
Scientists don’t know why some people with a particular variation in their DNA develop cancer, while others with the same variation don’t. 10X Genomics' technology suite enables the study of cells and systems at an unprecedented level of resolution.
In this article: TXG
Read
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Article By: Benzinga
Saturday, September 26, 2020 3:55 PM EDT
Biotech stocks reversed course last week, dragged lower by the broader market weakness. The week's news flow was headlined by Johnson & Johnson kickstarting a Phase 3 trial of its coronavirus vaccine candidate.
In this article: JNJ, CAPR, XNCR, MESO, ACIU, SBPH, VCNX, AQST, MGTX, ETON
Read
Week In Review: Illumina Pays $8 Billion To Acquire GRAIL, An Early-Stage Cancer Testing Company
Article By: ChinaBio® Today
Saturday, September 26, 2020 1:33 PM EDT
Illumina will acquire Grail, an Illumina spin-out that is developing an early screening test for multiple forms of cancer, for $8 billion in cash and stock. JD Health, a Beijing online healthcare company, plans to raise $3 billion in a Hong Kong IPO.
In this article: ILMN, SVA, ZLAB, LEGN
Read
FDA Vaccine Committee Head Steps Aside Over Conflict Of Interest With Moderna Role
Article By: Benzinga
Thursday, September 24, 2020 4:40 AM EDT
The head of the United States FDA’s vaccine advisory committee has recused herself from the panel due to her involvement in supervising the clinical trial of Moderna Inc’s COVID-19 vaccine.
In this article: MRNA Also: PFE, MSFT
Read
J&J In Final Stage COVID-19 Tests: Would You Take The Vaccine?
Article By: Mish Shedlock
Thursday, September 24, 2020 4:20 AM EDT
Johnson & Johnson (JNJ​​​​​​​) starts a 60,000 person phase-3 trial test. Stage-3 is the final phase.
In this article: JNJ Also: AZN, PFE
Read
Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021
Article By: Benzinga
Wednesday, September 23, 2020 9:45 AM EDT
Johnson & Johnson has joined the big league of frontrunners in the coronavirus vaccine race following its announcement concerning the initiation of the Phase 3 study.
In this article: JNJ Also: AZN, PFE, MRNA, BNTX
Read
Open Source Licensing Could Keep Big Pharma From Making Huge Profits Off Taxpayer-Funded Research
Article By: The Conversation
Wednesday, September 23, 2020 5:25 AM EDT
An international, multi-billion-dollar race is underway to develop a COVID-19 vaccine, and progress is moving at record speed, but with nationalistic, competitive undertones.
Read
E Market Briefing For Tuesday, Sept. 23
Article By: Gene Inger
Wednesday, September 23, 2020 2:23 AM EDT
Market 'anesthesia' - was expected to relieve the pain inflicted by super-cap selling, at least temporarily on Tuesday and perhaps even Wednesday, and that's what we've got going.
In this article: SRNE Also: LLY, SPX, VIX, HTBX
Read
E Market Briefing For Tuesday, Sept. 22
Article By: Gene Inger
Tuesday, September 22, 2020 2:25 AM EDT
Technical correction progression - keeps formerly 'hot stocks in cold storage' for at least now. Rebounds will occur of course, just as expected late Monday or during part of Tuesday's session.
In this article: JPM, LLY, SRNE, AMGN, SPX
Read
E The Canadian Cannabis Report - Monday, Sept. 21
Article By: James Coleman
Monday, September 21, 2020 10:39 PM EDT
The past, present, and future of the Canadian cannabis market based on a 25 stock index.
In this article: MJ, THCX, CNBS, ZBISF, NCNNF
Read
Time For The Newer Biotech Companies To Wake Up?
Article By: Michele Schneider
Sunday, September 20, 2020 11:09 AM EDT
With companies like Pfizer giving possible hope for an end of year vaccine and a recent gap up in IBB​​​​​​​ (Nasdaq Biotechnology ETF), now could be a good time to keep an eye on newer issues in this sector.
In this article: IBB, MRNA, BBIO, BNR, BEAM Also: QQQ, IWM, KRE, SMH, SPY, XRT
Read
Week In Review: Zai Lab To Raise Up To $845 Million In Hong Kong IPO
Article By: ChinaBio® Today
Saturday, September 19, 2020 1:56 PM EDT
Zai Lab​ of Shanghai is conducting a Hong Kong IPO that is expected to raise up to $845 million, offering 12.3% of the company's expanded number of shares. On the Nasdaq Exchange, Zai has a market capitalization of $6.2 billion.
In this article: PFE, FOSUF, ZLAB
Read
E Here's A Conservative Way To Invest In Pot Stocks
Article By: Lorimer Wilson
Friday, September 18, 2020 1:20 PM EDT
Seven major consumer and pharmaceutical corporations have bought into marijuana companies. Let's compare their stock performances YTD with those of their marijuana partners.
In this article: BUD, MO, NVS, STZ, TAP, CGC, ANCUF, CRON, CBWTF, TLRY, HEXO, IMBBY
Read
E Cytodyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
Article By: Moon Kil Woong
Friday, September 18, 2020 12:10 PM EDT
This is to clarify the recent conference call and counter misleading information on it by shorters etc.
In this article: CYDY Also: IMMU, GILD
Read
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
Article By: Benzinga
Thursday, September 17, 2020 10:48 AM EDT
Here's a roundup of top developments in the biotech space over the last 24 hours.
In this article: BMY, LLY, NVS, PFE, IMMP, AMGN, CLVS, TSLA, VRTX, MRNA, SBBP, VBIV, BNTX, CRDF, GTH, NCNA, KZR
Read
1 to 16 of 3660 Posts
1 2 3 ... 229